| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/12/264:00 PM | -$21.13 | -$10.56GAAP | +50.0% | ⚠ Check | — | $0 | — | — | |
| Q2 '26 | 7/27/264:35 PM | -$51.60 | -$23.28GAAP | +54.9% | ⚠ Check | — | $0 | — | -100% | |
| Q1 '26 | 5/14/264:10 PM | -$42.96 | -$62.88GAAP | -46.4% | ⚠ Check | — | $0 | — | -100% | |
| Q4 '25 | 4/15/263:57 PM | -$210.00 | $44.40GAAP | ⚠ Check | ⚠ Check | — | $0 | — | -100% | |
| Q3 '25 | 11/13/254:00 PM | -$156.00 | -$186.00GAAP | -19.2% | +66% | — | $0 | — | ⚠ Check | |
| Q2 '25 | 7/28/254:12 PM | -$246.00 | -$210.00GAAP | +14.6% | ⚠ Check | $0.40M | $0.85M | +113% | +183% | |
| Q1 '25 | 5/1/254:01 PM | -$396.00 | -$270.00GAAP | +31.8% | ⚠ Check | — | $1.64M | — | — |
⚠ Potential error in calculation, check manually. The two EPS figures may be on different share counts (a stock split one source has not adjusted for). Reported revenue shows as zero, which usually means the figure is missing.
GAAP = diluted EPS as filed with the SEC.